Navigation Links
Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
Date:9/23/2009

rocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications. More information is available at www.oxybiomed.com.

Caution Regarding Forward-Looking Statements

This news release contains certain forward-looking statements by Oxygen Biotherapeutics, Inc. that involve risks and uncertainties and reflect the company's judgment as of the date of this release. These statements include those referring to the start of a Phase II for Oxycyte in TBI. Actual events or results may differ from Oxygen Biotherapeutics, Inc.'s expectations. There can be no assurance that a sufficient number of patients will be enrolled in the trial nor any assurance of the outcomes. Additional information concerning these and other risk factors affecting Oxygen Biotherapeutics, Inc.'s business can be found in the company's public periodic filings with the Securities and Exchange Commission, which are available via www.oxybiomed.com. Oxygen Biotherapeutics, Inc. disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.


'/>"/>
SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
2. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
3. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
4. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
5. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
6. Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
7. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
8. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
9. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
10. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
11. Cytopias CYT387 Receives FDA Clearance to Start US Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015  Maetrics ( http://maetrics.com ), a leading ... wrapped up a successful conference, "The cost of non-compliance -- ... today in Zurich . ... its Switzerland -based team, experts provided ... Technology field to an exclusive local audience. The event ...
(Date:5/28/2015)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced that Chief ... is scheduled to present at the LD Micro Invitational ... Los Angeles . A live ... Event Calendar of the Investors section of IRIDEX,s website at ... available shortly after the conclusion of the presentation and will ...
(Date:5/28/2015)... The controversy surrounding the use of ... (procedures to remove uterine fibroids) continues, as a ... Johnson & Johnson,s Ethicon, Inc. unit, which was ... to the report published by The Wall Street ... is trying to determine what the company knew ...
Breaking Medicine Technology:Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... WINSTON-SALEM, N.C., Dec. 4 A new, $2.8 million, four-year ... School of Medicine and their collaborators at Wake Forest University ... degrades over time and how to address the problem. This ... increased risk for cardiovascular events and organ failure, particularly among ...
... FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: ... First Amended Plan of Reorganization and related amended Disclosure Statement ... Delaware. , A hearing to consider the adequacy ... 2009, with the hearing on the confirmation of the Plan ...
Cached Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3
(Date:5/30/2015)... Industry, CA (PRWEB) May 30, 2015 ... technology and foreign travelers who experienced OGAWA products while ... in the U.S. , A leader in the ... is a cutting-edge designer, researcher, developer and manufacturer of ... longevity and superior craftsmanship of their products, health enthusiasts ...
(Date:5/30/2015)... 2015 Wixom, Michigan: Proof. Pest Control, a family-owned ... a new twist to its robust line of services-a ... used for general pest management. , “We like ... Wixom Branch Manager. “The average person cringes when they see ... with problems that most people don’t even want to think ...
(Date:5/30/2015)... “ Milli the Snail ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... educates children. , Interactive mobile games for children have become ... games they are playing are doing much for their intellectual ...
(Date:5/29/2015)... “In the current environment of ... regulations, we provide education that will help practitioners ... suffering from pain, within the boundaries of the ... of rehabilitation medicine and President/Medical Director of the ... , A new flight of PAINWeekEnd Regional Conferences ...
(Date:5/29/2015)... 2015 M3 USA MDLinx.com, source of ... medical specialties, now offers The Smartest Rheumatologist . ... rheumatology disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis ... of MDLinx, and Caroline Tredway, editorial head of The ... will have on the physicians who participate. Says Tredway, ...
Breaking Medicine News(10 mins):Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:Proof. Pest Control-Now Offering 100% Organic Pest Control in Southeast Michigan 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2
... than half of older patients successfully treated for colorectal ... recurrence of cancer. The study, appearing in the October ... journal of the American Cancer Society, indicates poor compliance ... survival. , Patients who undergo potentially curative surgery for ...
... been linked recently to patient deaths , , SUNDAY, ... formulation of the injectable diabetes drug Byetta controls ... formulation, researchers report. , "Besides obvious improved ease ... advantage of both improved efficacy on glucose control ...
... Without Their Companions; Hurricane Gustav Pet Evacuation Efforts Confirm ... ... A 2007 survey by the American Humane,Association found that 47 percent ... family pet. With Hurricanes,Hanna, Ike and Josephine moving towards the U.S. ...
... Speaker Nancy Pelosi,issued the following statement today in support of ... aired on all networks tonight:, "There is not a ... one,suffer because of cancer. Cancer kills 565,000 Americans annually, and ... Americans must work,together to make eradicating the scourge of cancer ...
... Sept. 5 EthicAd, a nonprofit organization,devoted to ... of a new FDA Web site created to ... of prescription,medications. The site, "Be Smart About Prescription ... Drug Evaluation and Research and was,developed by the ...
... may take medications for years to help keep their ... to anti-hormonal drugs, treatment with chemotherapy becomes the only ... ASCO Breast Cancer Symposiummay change this approach. Early ... tumor, allowing anti-hormonal drugs to do their job once ...
Cached Medicine News:Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Once-Weekly Diabetes Drug Boosts Blood Sugar Control 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:1 step back ... 2 steps forward 2
Smooth pointed tips open to 3.0 mm. 45 degree cross action angled shafts. Tip to Angle Length: 12.0 mm. Round handle....
Flat handle 9 mm wide, angulated 45....
Straight shafts with pointed tips and 6 mm tying platform. Smooth handle with dull finish. Fine pointed tips....
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model....
Medicine Products: